,22 To further improve the efficacy of Delta-24-RGD, we modified the agent to express the immune costimulatory OX40 ligand (OX40L), which is known to enhance tumor-specific T cell activation as well as the antigen-presenting capabilities of tumor cells.23 This evidence concerns the gene TNFSF4 and neoplasm.